MARKET

FBIOP

FBIOP

Fortress Biotech Inc
NASDAQ
5.19
-0.06
-1.14%
Closed 15:58 04/11 EDT
OPEN
5.33
PREV CLOSE
5.25
HIGH
5.33
LOW
5.10
VOLUME
8.53K
TURNOVER
--
52 WEEK HIGH
17.47
52 WEEK LOW
4.860
MARKET CAP
17.79M
P/E (TTM)
-1.9301
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at FBIOP last week (0331-0404)?
Weekly Report · 4d ago
FORTRESS BIOTECH, INC. ANNUAL REPORT ON FORM 10-K
Press release · 03/31 22:34
Fortress Biotech Inc reports results for the quarter ended December 31 - Earnings Summary
Reuters · 03/31 21:00
FORTRESS BIOTECH REPORTS 2024 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS
Reuters · 03/31 20:05
Weekly Report: what happened at FBIOP last week (0324-0328)?
Weekly Report · 03/31 10:00
Fortress Biotech Inc <FBIO.OQ> expected to post a loss of 75 cents a share - Earnings Preview
Reuters · 03/28 20:27
JOURNEY MEDICAL CORPORATION LAUNCHES EMROSI™ (40 MG MINOCYCLINE HYDROCHLORIDE MODIFIED-RELEASE CAPSULES, 10 MG IMMEDIATE RELEASE AND 30 MG EXTENDED RELEASE) FOR THE TREATMENT OF ROSACEA
Reuters · 03/24 12:30
Weekly Report: what happened at FBIOP last week (0317-0321)?
Weekly Report · 03/24 09:55
More
About FBIOP
More
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has seven marketed prescription pharmaceutical products and over 25 programs in development at the Company, at its majority-owned and majority-controlled partners and subsidiaries and at partners and subsidiaries it founded and in which it holds significant minority ownership positions. Such product candidates span six market areas, including oncology, rare diseases and gene therapy. Its dermatology products include Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Exelderm and Luxamend. Its late stage product candidates include Cosibelimab (anti-PD-L1 antibody), DFD-29 (modified release oral minocycline for the treatment of rosacea), CUTX-101 (copper histidinate injection for Menkes disease), IV Tramadol, Olafertinib (also known as CK-101, EGFR inhibitor for EGFR mutation-positive NSCLC), CAEL-101 (monoclonal antibody for AL amyloidosis) and Triplex (cytomegalovirus (CMV) vaccine).
Recently
Symbol
Price
%Change
    SLN
  • 2.570
  • +17.35%

Webull offers Fortress Biotech Inc stock information, including NASDAQ: FBIOP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBIOP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FBIOP stock methods without spending real money on the virtual paper trading platform.